These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30240375)

  • 1. [Rational hypoglycemic therapy - nephro-diabetologic view].
    Kosmalski M; Kurnatowska I
    Pol Merkur Lekarski; 2018 Aug; 45(266):81-88. PubMed ID: 30240375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic kidney disease and new antidiabetic drugs : an overview in 2019].
    Andrade Lopes S; Jornayvaz FR; De Seigneux S
    Rev Med Suisse; 2019 May; 15(653):1106-1111. PubMed ID: 31148421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT-2 inhibition in patients with kidney disease.
    Gilbert RE
    Diabetes Metab; 2014 Dec; 40(6 Suppl 1):S23-7. PubMed ID: 25554068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting].
    Granata A; Insalaco M; Di Nicolò P; Scarfia VR; Russo L; D'anna G; Lentini P; Fiorini F; Fatuzzo P
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.
    Betônico CC; Titan SM; Correa-Giannella ML; Nery M; Queiroz M
    Clinics (Sao Paulo); 2016 Jan; 71(1):47-53. PubMed ID: 26872083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and strategies for early detection and management of diabetic kidney disease.
    Radbill B; Murphy B; LeRoith D
    Mayo Clin Proc; 2008 Dec; 83(12):1373-81. PubMed ID: 19046557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of diabetes in patients with chronic kidney disease.
    Ahmed Z; Simon B; Choudhury D
    Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
    Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
    Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA; Tuttle KR
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for managing kidney disease in patients with diabetes.
    Thomas MC
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):55-70. PubMed ID: 23330907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia in patients with diabetes mellitus and renal impairment.
    Hettige TS; Cooper ME
    Diab Vasc Dis Res; 2017 Mar; 14(2):166-168. PubMed ID: 28128009
    [No Abstract]   [Full Text] [Related]  

  • 13. [CME: Antidiabetics in renal failure and kidney transplantation].
    Seer C; Lehmann R
    Praxis (Bern 1994); 2016 Jan; 105(2):69-74; quiz 75-6. PubMed ID: 26787327
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for better diabetes treatment for improved renal outcome.
    Rossing P; de Zeeuw D
    Kidney Int Suppl; 2011 Mar; (120):S28-32. PubMed ID: 21358699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document for the detection and management of chronic kidney disease].
    Martínez-Castelao A; Górriz JL; Bover J; Segura-de la Morena J; Cebollada J; Escalada J; Esmatjes E; Fácila L; Gamarra J; Gràcia S; Hernández-Moreno J; Llisterri-Caro JL; Mazón P; Montañés R; Morales-Olivas F; Muñoz-Torres M; de Pablos-Velasco P; de Santiago A; Sánchez-Celaya M; Suárez C; Tranche S
    Endocrinol Nutr; 2014 Nov; 61(9):e25-43. PubMed ID: 25171835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular protection of diabetic patient with chronic renal disease and particular case of end-stage renal disease in elderly patients].
    Zaoui P; Hannedouche T; Combe C
    Nephrol Ther; 2017 Jun; 13(6S):6S16-6S24. PubMed ID: 29463395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m
    Jourde-Chiche N; Guerrot D; Chauveau D; Boffa JJ
    Nephrol Ther; 2017 May; 13(3):138-145. PubMed ID: 28010941
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.